Ketasma Research Overview
Ketasma 1 mg is a pharmaceutical-grade antihistamine compound manufactured by Sun Pharmaceuticals Industries, containing ketotifen fumarate as the active ingredient. Ketotifen is a benzocycloheptathiophene derivative classified as a histamine H1 receptor antagonist with additional mast cell stabilising properties. Research scientists investigating antihistamine mechanisms and allergic response pathways frequently study ketotifen compounds in controlled laboratory environments. Our Stroid UK Shop maintains strict quality standards for all pharmaceutical preparations used in academic and commercial research settings.
Laboratory Research Applications
Ketotifen demonstrates dual pharmacological activities that make it valuable for multiple research applications. As an H1 receptor antagonist, it competitively blocks histamine binding sites, while its mast cell stabilising properties prevent degranulation and mediator release in cell culture models. Researchers studying allergic inflammation often examine ketotifen’s effects on cytokine production and eosinophil activation pathways. The compound’s oral bioavailability and extended half-life characteristics make it suitable for pharmacokinetic studies. Scientists investigating our ketotifen preparations frequently compare its activity profile against other antihistamine classes. Additionally, ketotifen’s prophylactic properties in asthma models provide insights into preventive therapeutic mechanisms. Research groups studying inflammatory mediator cascades often incorporate ketotifen into their experimental protocols alongside compounds from our SARMs collection for comparative anti-inflammatory studies.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Ketotifen Fumarate |
| Strength | 1 mg per tablet |
| Manufacturer | Sun Pharmaceuticals Industries |
| Formulation | Oral tablet |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | Antihistamine, mast cell studies |
Sun Pharmaceuticals Industries produces this pharmaceutical preparation under GMP conditions, ensuring consistent quality for research applications. The 1 mg dosage strength provides precise measurement capabilities for dose-response studies in laboratory settings. Researchers examining peptide-based therapeutics from our peptides range often use ketotifen as a control compound in inflammation studies.
Research Use Compliance
Ketasma 1 mg tablets are supplied exclusively for in-vitro research and laboratory analysis purposes. This product is not intended for human consumption, clinical use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory protocols and disposal procedures when handling pharmaceutical preparations. All studies should be conducted by qualified personnel with proper safety equipment and institutional oversight.
